![](/img/cover-not-exists.png)
Low disease activity - irrespective of serologic status at baseline - associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
Fanouriakis, Antonis, Adamichou, Christina, Koutsoviti, Sofia, Panopoulos, Stylianos, Staveri, Chrysanthi, Klagou, Anastasia, Tsalapaki, Christina, Pantazi, Lamprini, Konsta, Styliani, Mavragani, ClioLanguage:
english
Journal:
Seminars in Arthritis and Rheumatism
DOI:
10.1016/j.semarthrit.2018.02.014
Date:
February, 2018
File:
PDF, 832 KB
english, 2018